Yang, Shuansuo <br/><br/>
Fosinoprilat alleviates lipopolysaccharide (LPS)-induced inflammation by inhibiting TLR4/NF-κB signaling in monocytes.  [electronic resource] 

 -  Cellular immunology   
 - 182-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1090-2163 
<br/><br/><label>Standard No.: </label>10.1016/j.cellimm.2013.06.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Blotting, Western<br/>Cell Line<br/>Flow Cytometry<br/>Fosinopril--analogs & derivatives<br/>Humans<br/>Inflammation--drug therapy<br/>Interleukin-1beta--immunology<br/>Interleukin-6--immunology<br/>Monocytes<br/>NF-kappa B--antagonists & inhibitors<br/>RNA, Messenger--chemistry<br/>Real-Time Polymerase Chain Reaction<br/>Signal Transduction--drug effects<br/>Toll-Like Receptor 4--antagonists & inhibitors<br/>Tumor Necrosis Factor-alpha--immunology